Diet plan for a 10month old child with weight 7 kg in india
diet plan 10 month old baby India complementary feeding WHO guidelines 2024
complementary feeding infant 6-12 months India
10 month baby diet plan India 7kg underweight complementary feeding schedule Indian foods
https://gkfooddiary.com/10-months-indian-baby-food-chart
| Time | What to Give |
|---|---|
| Early Morning (wake-up, ~6-7 AM) | Breast milk or formula |
| Breakfast (~8-9 AM) | Soft semi-solid - see options below |
| Mid-Morning (~11 AM) | Breast milk or formula |
| Lunch (~12-1 PM) | Main solid meal - see options below |
| Evening Snack (~3-4 PM) | Fruit / finger food - see options below |
| Dinner (~6-7 PM) | Solid meal - see options below |
| Bedtime (~9 PM) | Breast milk or formula |
| Day | Breakfast | Lunch | Evening Snack | Dinner |
|---|---|---|---|---|
| Day 1 | Wheat dosa / wheat halwa with ghee | Moong dal khichdi with mashed vegetables + ghee | Mashed banana or papaya pieces | Ragi porridge with banana |
| Day 2 | Soft idli with coconut chutney (mild) | Curd rice with homemade curd + grated carrot | Cooked carrot / peas pieces (finger food) | Vegetable-stuffed soft paratha with ghee |
| Day 3 | Vegetable suji (semolina) upma | Mashed rice with tomato rasam + a tsp ghee | Banana pancake / bread omelette | Soft chapati dipped in dal |
| Day 4 | Dalia (broken wheat) porridge with milk | Rice + dal + paneer mashed together | Apple-carrot puree / pumpkin kheer | Steamed idli or dosa |
| Day 5 | Ragi porridge with mashed apple | Mixed vegetable rice or egg rice | Chikoo / apple milkshake (with breast milk or formula) | Moong dal khichdi with ghee |
| Day 6 | Bread upma / whole wheat toast fingers | Spinach rice / mashed ghee rice + egg yolk | Plain curd with mashed fruit | Poha upma or moong dal chilla |
| Day 7 | Health mix porridge | Dal rice (toor dal) + ghee | Scrambled egg / crumbled paneer | Suji kheer or banana halwa |
| Avoid | Reason |
|---|---|
| Cow's milk as main drink | Not suitable before 1 year (can use in cooking) |
| Salt, sugar, jaggery added to food | Kidney immaturity; taste preference reasons |
| Honey | Risk of infant botulism |
| Whole nuts | Choking hazard |
| Citrus fruits (lemon, orange) | Risk of rash/allergy |
| Carbonated drinks, packaged juices | No nutritional value |
| Spicy food with chilli | Gut irritation |
Diet plan for 10 month oldchild with weight 9 kg with calories content and protein of food
10 month old baby calorie protein requirement WHO India complementary feeding 2023
complementary feeding infant energy protein requirements 6-12 months
https://nin.res.in/dietaryguidelines/pdfjs/locale/DGI_2024.p…
Indian foods calorie protein content per 100g dal khichdi ragi egg curd banana NIN ICMR
| Nutrient | Total Daily Requirement | From Breast Milk / Formula | From Complementary Foods |
|---|---|---|---|
| Energy | 720 kcal/day | ~335 kcal | ~385 kcal |
| Protein | 10.5 g/day | ~5 g | ~5.5 g |
| Feeds | 4-5 breastfeeds or formula feeds/day | - | 3 meals + 1 snack |
Source: ICMR-NIN Dietary Guidelines for Indians 2024 - Total energy 720 kcal/day for 9-12 months; complementary foods provide 385 kcal/day; balance 335 kcal from breast milk.
| Food Item | Serving Size | Calories (kcal) | Protein (g) | Notes |
|---|---|---|---|---|
| Moong dal khichdi (rice 15g + dal 10g, cooked) | 3/4 katori (~60g cooked) | ~70 kcal | ~2.8 g | Add ghee for extra calories |
| Ragi porridge (ragi 15g + milk) | 1/2 katori | ~65 kcal | ~1.8 g | Best calcium source for babies |
| Idli (2 small) | ~40g | ~55 kcal | ~1.8 g | Fermented = better iron absorption |
| Soft dosa / wheat dosa | 1 small (~30g) | ~60 kcal | ~1.5 g | |
| Dalia (broken wheat) porridge (15g + milk) | 1/2 katori | ~70 kcal | ~2.2 g | |
| Egg yolk (boiled) | 1 yolk (~20g) | ~34 kcal | ~1.7 g | Daily is safe and recommended |
| Whole boiled egg | 1 egg (~50g) | ~68 kcal | ~6.6 g | Best protein per serving |
| Paneer (homemade) | 2 tbsp (~30g) | ~75 kcal | ~5.0 g | Highest protein dairy option |
| Full-fat curd (homemade) | 3 tbsp (~50g) | ~30 kcal | ~1.6 g | Probiotic + calcium |
| Banana (ripe, mashed) | 1/2 medium (~50g) | ~54 kcal | ~0.7 g | Best energy-dense fruit |
| Papaya (mashed) | 50g | ~20 kcal | ~0.3 g | Rich in Vit A + C |
| Sweet potato (mashed) | 50g cooked | ~45 kcal | ~0.7 g | Excellent carbohydrate source |
| Spinach rice (rice 15g + spinach 20g) | 3/4 katori | ~65 kcal | ~2.1 g | Iron-rich |
| Toor dal (cooked, 10g raw) | 3 tbsp | ~35 kcal | ~2.3 g | |
| Ghee | 1 tsp (5g) | 45 kcal | 0 g | Add to every meal for calorie boost |
| Breast milk (per feed, ~120-150 ml) | 1 feed | ~80-100 kcal | ~1.2 g |
| Meal | Calories | Protein |
|---|---|---|
| Early morning BM | 90 kcal | 1.2 g |
| Breakfast (ragi + banana) | 119 kcal | 2.5 g |
| Mid-morning BM | 90 kcal | 1.2 g |
| Lunch (khichdi + ghee) | 115 kcal | 2.8 g |
| Evening snack (paneer) | 75 kcal | 5.0 g |
| Dinner (dalia + ghee) | 115 kcal | 2.8 g |
| Bedtime BM | 90 kcal | 1.2 g |
| TOTAL | ~694 kcal | ~16.7 g |
| Day | Breakfast | Lunch | Evening Snack | Dinner |
|---|---|---|---|---|
| Mon | Ragi porridge + banana | Moong dal khichdi + ghee | Mashed papaya + curd | Dalia porridge + ghee |
| Tue | Soft idli + curd | Curd rice + mashed spinach | Crumbled paneer | Soft chapati in dal |
| Wed | Wheat dosa + coconut chutney (mild) | Spinach rice + egg yolk + ghee | Banana mash | Suji kheer with milk |
| Thu | Dalia porridge with milk | Rice + toor dal + sweet potato + ghee | Fruit smoothie (BM + banana) | Moong dal khichdi |
| Fri | Health mix porridge | Dal rice + scrambled egg + ghee | Boiled peas (finger food) | Vegetable upma + ghee |
| Sat | Banana pancake (wheat + banana) | Mixed veg khichdi + ghee | Full-fat curd | Ragi halwa with jaggery-free milk |
| Sun | Oats porridge with apple | Paneer rice + ghee | Chikoo puree | Soft chapati + dal |
Note: These values are based on the ICMR-NIN Dietary Guidelines for Indians 2024 and Indian Food Composition Tables 2017. A 9 kg baby at 10 months is at a healthy weight - maintain regular growth monitoring with your pediatrician every 1-2 months.
Paracetam drug
paracetamol pharmacology mechanism of action dose toxicity clinical uses 2024
paracetamol acetaminophen metabolism NAPQI hepatotoxicity pathway diagram

A comprehensive pharmacology and pathophysiology diagram illustrating the metabolic pathways and mechanism of action of paracetamol (acetaminophen). The schematic details three primary metabolic routes in the liver: glucuronidation (via UGT) and sulfation (via SULT) producing nontoxic metabolites for renal excretion, and a cytochrome P450-mediated pathway (CYP2E1, CYP3A4) forming the toxic intermediate N-acetyl-p-benzoquinone-imine (NAPQI). It depicts the detoxification of NAPQI by glutathione (GSH) and the adverse effects of excessive NAPQI, including mitochondrial oxidation and hepatotoxicity. The diagram also shows the N-deacetylation of paracetamol to p-aminophenol, leading to the formation of AM404, which activates TRPV1, TRPA1, and CBR1/2 receptors to provide analgesia. Furthermore, it illustrates the inhibition of the prostaglandin endoperoxide H synthase (PGHS) complex at the peroxidase (POX) site, preventing the conversion of PGG2 to PGH2, thereby explaining the drug's antipyretic and analgesic effects. Target receptors such as TRPV4 are also noted as potential sites of pharmacological interaction.

This pathophysiology diagram illustrates the biochemical mechanisms of Acetaminophen (APAP) induced hepatotoxicity within a mitochondrion. The process begins with APAP metabolism into NAPQI, which subsequently triggers the mitochondrial respiratory chain (MRC) to produce superoxide anions (O2.-). The diagram traces two primary pathways for these reactive species: 1) The reaction of O2.- with nitric oxide (NO) to form peroxynitrite (ONOO-), a potent mediator of nitrosative stress leading to hepatotoxicity. 2) The detoxification pathway involving superoxide dismutase 2 (SOD2), which converts O2.- into hydrogen peroxide (H2O2). The H2O2 is further neutralized to water (H2O) via the glutathione system, involving glutathione (GSH), glutathione disulfide (GSSG), and glutathione reductase (GR), though a downward arrow indicates GSH depletion. Pharmacological intervention is represented by SOD mimetics, which are shown to inhibit ONOO- formation, while their secondary effect on increasing H2O2 levels is noted as uncertain with a question mark. This educational visual explains the interplay between oxidative/nitrosative stress and mitochondrial dysfunction in drug-induced liver injury.

A pathophysiology diagram illustrating the central analgesic mechanisms of acetaminophen (paracetamol). The schematic outlines a metabolic pathway starting from the liver, where acetaminophen is converted into p-aminophenol. In the presence of the enzyme fatty acid amide hydrolase (FAAH), p-aminophenol is further metabolized into the active compound AM404 (N-acylphenolamine). The diagram demonstrates that AM404 acts on both the brain and the spinal cord through several neurotransmitter systems and receptors. In the brain, AM404 is shown to interact with cyclooxygenase (COX), anandamide, cannabinoid 1 (CB1) receptors, transient receptor potential vanilloid 1 (TRPV1) receptors, opioid receptors, and 5-HT3 receptors. In the spinal cord cross-section, the mechanism focuses on interactions with TRPV1 and CB1 receptors. The visual uses anatomical illustrations of the liver, brain, and spinal cord linked by arrows to signify the metabolic progression and central site of action, highlighting the drug's complex pharmacodynamics beyond simple COX inhibition.
| Property | Details |
|---|---|
| Generic name | Paracetamol (INN) / Acetaminophen (USAN) |
| Drug class | Non-opioid analgesic, Antipyretic |
| Chemical class | Para-aminophenol derivative |
| Origin | Metabolite of phenacetin (older analgesic now withdrawn) |
| Availability | OTC and prescription; oral, rectal, IV formulations |

| Parameter | Details |
|---|---|
| Absorption | Rapid and complete after oral administration; onset ~30 min (PO) |
| IV onset | 5-10 minutes |
| Rectal onset | Slower, variable absorption - higher dose required |
| Peak plasma | 30-60 minutes (oral) |
| Duration | 4-6 hours |
| Protein binding | 10-25% |
| Metabolism | Hepatic - mainly glucuronidation (60%) and sulfation (30%); ~5-10% via CYP2E1/CYP3A4 to NAPQI |
| Half-life | Neonates: 7 hours; Infants: 4 hours; Children/adolescents: 3 hours; Adults: 2 hours |
| Excretion | Renal (as conjugates) |
| Indication | Notes |
|---|---|
| Mild-to-moderate pain | Headache, myalgia, toothache, dysmenorrhoea, osteoarthritis pain |
| Fever (pyrexia) | Drug of choice in children (preferred over aspirin - no Reye's syndrome risk) |
| Post-operative analgesia | IV form commonly used perioperatively |
| Musculoskeletal pain | First-line for osteoarthritis (lower GI and CV risk vs NSAIDs) |
| Migraine | Component of combination analgesics |
| Pain in pregnancy | Considered safest analgesic in pregnancy |
| Patients on anticoagulants | Preferred over NSAIDs (no platelet inhibition at standard doses) |
| Route | Dose | Frequency | Max per day |
|---|---|---|---|
| Oral / Rectal | 500-1000 mg | Every 4-6 hours | 4000 mg (4 g) |
| IV (Ofirmev) | 1000 mg | Every 6 hours | 4000 mg |
| Age | Dose |
|---|---|
| General pediatric | 10-15 mg/kg/dose every 4-6 hours |
| Max single dose | 15 mg/kg or 1000 mg (whichever is less) |
| Max daily | 60-75 mg/kg/day, not exceeding 4 g/day |
Reduce dose in: Liver disease, alcoholism, chronic malnutrition, neonates/infants (longer half-life)

Paracetamol (overdose)
↓ CYP2E1 / CYP3A4 (liver)
NAPQI (N-acetyl-p-benzoquinone imine) — highly reactive toxic metabolite
↓ (normally neutralized by glutathione/GSH)
Cysteine + mercapturic acid (harmless, excreted in urine)
BUT in overdose:
GSH stores depleted → NAPQI accumulates
↓
Mitochondrial oxidative stress → Superoxide (O2•⁻) → Peroxynitrite (ONOO⁻)
↓
CENTRILOBULAR LIVER NECROSIS → Acute Liver Failure
| Stage | Time | Features |
|---|---|---|
| Stage I - GI | 0-24 hours | Nausea, vomiting (deceptively mild); patient fully conscious - false sense of security |
| Stage II - Latent | 24-72 hours | Apparent improvement; subclinical liver damage; anorexia, malaise, right hypochondrial pain |
| Stage III - Hepatic failure | 3-5 days | Jaundice, coagulopathy, encephalopathy, renal tubular necrosis, cerebral oedema, cardiomyopathy, GI haemorrhage |
| Stage IV | If survived | Complete resolution of liver injury in survivors |
| Condition | Guidance |
|---|---|
| Severe hepatic impairment | Avoid or use with extreme caution; reduce dose |
| Chronic alcoholism | Reduce max daily dose to 2 g/day |
| G6PD deficiency | Use with caution (risk of haemolysis) |
| Renal impairment | Extend dosing interval (every 6-8 hours) |
| Pregnancy | Safe - drug of choice for pain/fever |
| Neonates / Infants | Reduce dose (longer half-life - 4-7 hours) |
| Drug | Interaction |
|---|---|
| Warfarin | Paracetamol at >2 g/day can enhance anticoagulant effect (INR monitoring needed) |
| Alcohol | Increases NAPQI formation → hepatotoxicity risk |
| Enzyme inducers (rifampicin, phenytoin, carbamazepine) | Increased CYP2E1 activity → more NAPQI production → higher hepatotoxicity risk |
| Isoniazid | Increases hepatotoxicity risk |
| Probenecid | Inhibits paracetamol conjugation → increases half-life and plasma levels |
| Metoclopramide | Increases absorption rate of paracetamol |
| Property | Paracetamol | NSAIDs | Aspirin |
|---|---|---|---|
| Analgesic | Yes | Yes (stronger) | Yes |
| Antipyretic | Yes | Yes | Yes |
| Anti-inflammatory | No (peripheral) | Yes | Yes |
| GI side effects | None | Yes | Yes |
| Platelet inhibition | No | Yes | Yes (irreversible) |
| Renal toxicity | Minimal | Yes | Yes |
| CV risk | None | Yes (COX-2 selective) | No (cardioprotective) |
| Safe in pregnancy | Yes | Avoid 3rd trimester | Avoid 3rd trimester |
| Safe in children | Yes | Ibuprofen preferred | Contraindicated (Reye's) |